|
|
Pharmaceuticals
| ||||||||||||||||||||||||||||||||
|
|
| ||||||||||||||||||||||||||||||
|
Current Pharmaceuticals News Today MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment In Open-Label Trial And Completion Of ... MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that all non-asthmatic patients and a subset of asthmatic patients have completed 12 months of treatment in the open-label safety trial of LEVADEX™. Thu, 09 Sep 2010 04:30:06 -0700 Cempra Pharmaceuticals Initiates Both A Phase 2 Study With An Oral Formulation And A Phase 1 Study Of The Intravenous ... Cempra Pharmaceuticals announced that it is moving forward in its dual approach to the development of solithromycin (CEM-101), a fluoroketolide which is first of a new generation of macrolide-ketolide antibiotics for treatment of community-acquired bacterial pneumonia (CABP). Thu, 09 Sep 2010 01:47:18 -0700 Syndax Pharmaceuticals to Present at R.W. Baird 2010 Healthcare Conference and BioPharm America 2010 WALTHAM, Mass., Sept. 9 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that Joanna Horobin, M.D., the company's president and CEO, will present an overview of upcoming milestones including the ongoing phase 2 clinical program for entinostat in breast, lung, colorectal cancer and hematologic malignancies, at the following conferences ... Thu, 09 Sep 2010 06:31:22 -0700 Cempra Pharmaceuticals Will Present New Data on Solithromycin (CEM-101) and TAKSTA (CEM-102) at the 50th Interscience ... Cempra Pharmaceuticals today announced its schedule of 16 poster presentations at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy in Boston, Mass., on September 12-15, 2010. Thu, 09 Sep 2010 05:00:00 -0700 NovaBay Pharmaceuticals to deliver data on Aganocide compounds at ICAAC Conference NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, will deliver four poster presentations on its compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Thu, 09 Sep 2010 00:07:32 -0700 |
| Copyright 2006-2008 by Sleek Seo Web Directory All Rights Reserved Power : PHPLD |
